taking tirzepatide and retatrutide together vs. Tirzepatide: What's The Difference? – Forbes Health The truth about combining retatrutide

This is why monitoring increases during GLP-1 therapynot because the drugs chemically interact, but because your physiology is changing

Reported incidences in those receiving a 12mg/weekly dose of retatrutide were [21]: Nausea (45% of participants) Vomiting (19%) Constipation (16%) Diarrhea (15%) Cardiac arrhythmia (11%) Fatigue (10%) Increased pancreatic enzyme (lipase) levels (8%) Injection site reactions (8%) Liver issues in 2 participants (3%) Pancreatitis in 1 participant (2%) Both tirzepatide and retatrutide share similar contraindications, including advice against their use during pregnancy and breastfeeding

clinical trial registration number NCT02759107) (57)

UCSF Health recommends regular leg exercises as part of managing venous disease